|
Market Closed -
Australian S.E.
10:40:30 27/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.3100 AUD | -4.62% |
|
+6.90% | -52.31% |
| Market Cap | 9.48Cr 6.67Cr 5.98Cr 5.52Cr 5.01Cr 9.36Cr 633.25Cr 66Cr 26Cr 331.92Cr 25Cr 24Cr 1.05TCr | P/E 2027 * |
-1.94x | P/E 2028 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 15Cr 11Cr 9.43Cr 8.71Cr 7.9Cr 15Cr 998.19Cr 104.41Cr 41Cr 523.21Cr 39Cr 39Cr 1.66TCr | EV / Sales 2027 * |
20.8x | EV / Sales 2028 * | 4.43x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -4.62% | ||
| 1 week | +6.90% | ||
| Current month | -1.59% | ||
| 1 month | -6.06% | ||
| 3 months | -13.89% | ||
| 6 months | -41.51% | ||
| Current year | -52.31% |
| 1 week | 0.3 |  | 0.36 |
| 1 month | 0.26 | | 0.36 |
| Current year | 0.26 | | 0.73 |
| 1 year | 0.26 | | 0.73 |
| 3 years | 0.26 | | 0.73 |
| 5 years | 0.26 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 28/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 01/10/2012 |
James Graham
BRD | Director/Board Member | - | 01/05/2012 |
| Director/Board Member | - | 01/09/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/07/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/07/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.62% | +6.90% | -26.19% | -31.11% | 6.97Cr | |
| -0.15% | -0.36% | +54.77% | +128.30% | 1,14000Cr | |
| +0.75% | +3.62% | +41.22% | +84.57% | 64TCr | |
| -0.12% | -0.88% | +25.66% | +106.25% | 51TCr | |
| +0.63% | +2.33% | +49.21% | +67.82% | 38TCr | |
| +0.90% | -4.38% | +61.15% | +37.92% | 35TCr | |
| +1.02% | +1.80% | +24.84% | +53.75% | 29TCr | |
| -0.25% | +1.62% | +2.20% | +26.65% | 27TCr | |
| +0.46% | +1.69% | +53.30% | +70.64% | 24TCr | |
| -0.40% | +0.80% | +30.95% | +105.89% | 20TCr | |
| Average | -0.22% | +3.84% | +31.71% | +65.07% | 40.14TCr | |
| Weighted average by Cap. | +0.23% | +2.98% | +42.02% | +88.22% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 72L 50.64L 45.45L 41.97L 38.06L 71.13L 48Cr 5.03Cr 2Cr 25Cr 1.9Cr 1.86Cr 80Cr | 2.46Cr 1.73Cr 1.55Cr 1.43Cr 1.3Cr 2.43Cr 164.34Cr 17Cr 6.83Cr 86Cr 6.49Cr 6.36Cr 273.17Cr |
| Net income | -4.72Cr -3.32Cr -2.98Cr -2.75Cr -2.49Cr -4.66Cr -315.31Cr -33Cr -13Cr -165.27Cr -12Cr -12Cr -524.1Cr | 61L 42.9L 38.51L 35.55L 32.24L 60.26L 41Cr 4.26Cr 1.69Cr 21Cr 1.61Cr 1.58Cr 68Cr |
| Net Debt | 5.46Cr 3.84Cr 3.45Cr 3.18Cr 2.89Cr 5.4Cr 364.94Cr 38Cr 15Cr 191.29Cr 14Cr 14Cr 606.6Cr | 1.42Cr 99.87L 89.64L 82.77L 75.05L 1.4Cr 95Cr 9.92Cr 3.94Cr 50Cr 3.75Cr 3.67Cr 157.68Cr |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | A$0.3100 | -4.62% | 2,02,951 |
| 26/26/26 | A$0.3250 | -2.99% | 40,554 |
| 23/26/23 | A$0.3350 | -2.90% | 1,26,535 |
| 22/26/22 | A$0.3450 | -2.82% | 69,173 |
| 21/26/21 | A$0.3550 | +1.43% | 2,03,787 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
